Refine
Departments, institutes and facilities
- Institut für funktionale Gen-Analytik (IFGA) (4) (remove)
Document Type
- Article (4)
Language
- English (4)
Has Fulltext
- no (4)
Keywords
- Enzyme activity (1)
- Fatty acid metabolism (1)
- Ketogenesis (1)
- Ketone body synthesis (1)
- Leucine degradation (1)
- Organic aciduria (1)
Propionic acidemia in a previously healthy adolescent with acute onset of dilated cardiomyopathy
(2014)
BACKGROUND
Hyperlysinemia is an autosomal recessive inborn error of L-lysine degradation. To date only one causal mutation in the AASS gene encoding α-aminoadipic semialdehyde synthase has been reported. We aimed to better define the genetic basis of hyperlysinemia.
METHODS
We collected the clinical, biochemical and molecular data in a cohort of 8 hyperlysinemia patients with distinct neurological features.
RESULTS
We found novel causal mutations in AASS in all affected individuals, including 4 missense mutations, 2 deletions and 1 duplication. In two patients originating from one family, the hyperlysinemia was caused by a contiguous gene deletion syndrome affecting AASS and PTPRZ1.
CONCLUSIONS
Hyperlysinemia is caused by mutations in AASS. As hyperlysinemia is generally considered a benign metabolic variant, the more severe neurological disease course in two patients with a contiguous deletion syndrome may be explained by the additional loss of PTPRZ1. Our findings illustrate the importance of detailed biochemical and genetic studies in any hyperlysinemia patient.